Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2026-06-10 @ 7:17 AM
Study NCT ID:
NCT01025505
Status:
COMPLETED
Last Update Posted:
2022-10-12
First Post:
2009-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study
Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LAL1408
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None